Japanese journal of clinical oncology
-
Jpn. J. Clin. Oncol. · Jun 2012
Clinical features and survival analysis of T1mic, a, bN0M0 breast cancer.
To analyze the clinicopathological features and prognosis of T1mic, a, bN0M0 breast cancer. ⋯ Hormonal receptor and human epidermal growth factor receptor 2 were independent factors of 5-year disease-free survival for patients with T1mic, a, bN0M0 breast cancer. The Luminal B group had a worse prognosis than the Luminal A group, but there was no statistically significant difference between triple-negative and human epidermal growth factor receptor 2-positive groups.